It was previously shown that in mouse models of both genetic and pharmacological LIF blockade, loss of LIF resulted in significantly impaired tumor progression and augmented chemotherapy efficiency, prolonging survival by modulating cancer cell differentiation and EMT [78]. Here, LIF is linked to cancer.